Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by westcoast1000

T.ONC

RE:RE:RE:RE:asco abstract info

Thanks azzak.

June 3, 2023

T.ONC

RE:RE:RE:The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't

Same to you fox. You are a valuable voice here.

June 3, 2023

T.ONC

RE:asco abstract info

itntdf Are those the results released previously with data from November...

June 3, 2023

T.ONC

RE:ASCO

Vetnure,  I agree with your sentiment. However, scientists are not...

June 3, 2023

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:CAR-T Abstract from Mayo Clinic (Vile group) using pela

Folks, you may be discussing cures in mice cancer cells, not in live mice.

June 2, 2023

T.ONC

RE:CAR-T Abstract from Mayo Clinic (Vile group) using pela

The CAR-T results refer to murine model patients (mice) with high grade...

June 1, 2023

T.ONC

CAR-T Abstract from Mayo Clinic (Vile group) using pela

Here are the final two sections: Results:By using OV in combination with...

June 1, 2023

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:Wow factor still there

Azzak, preety funny! you are very good at this kind of repartee. I guess I...

May 30, 2023

T.ONC

RE:RE:Turning to Goblet

Thanks, askretka. That is October 20-24 in Madrid. Abstracts have already...

May 29, 2023

T.ONC

Turning to Goblet

Althought we are in the last week of waiting about the Bracelet updated data...

May 29, 2023

T.ONC

RE:IND213

Ionc, Thanks for these insightful  comments. I did not recall there was...

May 28, 2023

T.ONC

RE:RE:RE:RE:RE:Conditions are right for biopharma M&A to break out

Noteable you are being very disagreeable, and unprofessional to say the least...

May 28, 2023

T.ONC

RE:RE:Release

Well said, Yeg.

May 27, 2023

T.ONC

RE:load up load up

Formerly, I thought Quentin was a fretful and worried but sincere poster...

May 26, 2023

T.ONC

RE:RE:RE:RE:Why is the stock down?

"In the short term, the market is a voting machine. In the long term, it...

May 26, 2023

T.ONC

Crisis in visceral met breast cancer: clinical review

This clinical review is from April 2023. Thanks to ne2thezu on ST. ...

May 25, 2023

T.ONC

RE:RE:RE:RE:ONCY announces Pelareorep ≥50% ORR & mPFS Improvements

Good points, fox. 

May 25, 2023

T.ONC

RE:ASCO

Thanks to Ionc for finding the abstract and posting it. I am not conversant...

May 25, 2023

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:RE:Conditions are right for biopharma M&A to break out

Pretty funny, Azzak!

May 22, 2023

T.ONC

RE:RE:RE:RE:RE:RE:RE:RE:Conditions are right for biopharma M&A to break out

Quentin, I do not think they would sell the company for under $2 bil, with...

May 22, 2023

Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next

Featured Company

Spirit Blockchain Capital Inc.

Spirit Blockchain Capital Inc. C.SPIR

Spirit Blockchain Capital Inc. is an investment company focused on blockchain industry. Through its operational business line ... view more »